Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 34,696	$ 22,063	$ 92,271	$ 51,017
General and administrative	12,220	13,172	24,451	25,787
Total operating expenses	46,916	35,235	116,722	76,804
Loss from operations	(46,916)	(35,235)	(116,722)	(76,804)
Interest income and other, net	6,637	7,303	13,505	13,602
Loss before income taxes	(40,279)	(27,932)	(103,217)	(63,202)
Income tax expense	(243)	(251)	(474)	(448)
Net loss	(40,522)	(28,183)	(103,691)	(63,650)
Other comprehensive loss
Unrealized gain (loss) on available-for-sale investments	(99)	(3)	(487)	374
Comprehensive loss	$ (40,621)	$ (28,186)	$ (104,178)	$ (63,276)
Net loss per share - basic and diluted
Net loss per share - basic	$ (0.48)	$ (0.34)	$ (1.23)	$ (0.76)
Net loss per share - diluted	$ (0.48)	$ (0.34)	$ (1.23)	$ (0.76)
Weighted-average number of common shares - basic and diluted
Weighted-average number of common shares - basic	84,253,700	83,399,377	84,069,646	83,361,398
Weighted-average number of common shares - diluted	84,253,700	83,399,377	84,069,646	83,361,398